Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
ARVEE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Arvee Laboratories reported total income of ₹3,219.52 lakhs for FY 2025-26, down from ₹3,914.45 lakhs in the prior year — a revenue decline of approximately 17.5%. However, profit after tax grew to ₹252.63 lakhs from ₹214.74 lakhs in the prior year, an increase of about 17.6%, driven by cost controls and lower raw material consumption (₹1,818.90 lakhs vs ₹1,887.29 lakhs). EPS improved to ₹2.29 per share from ₹1.95. Total equity stands at ₹3,378.77 lakhs. The company operates in two segments: textile and non-textile, with non-textile contributing the majority of revenue (₹2,757.99 lakhs). The auditor issued an unmodified opinion with no qualifications.
Revenue declined year-on-year, which may concern investors, but the profit growth despite lower revenue signals improved operational efficiency. The clean audit opinion is a positive indicator for shareholder confidence.